Drug trial targets debilitating itch in liver patients
NCT ID NCT04256759
Summary
This small, exploratory study tested whether an existing medication called dupilumab could help reduce severe, chronic itching in adults with liver disease. Nine participants received the drug for 18 weeks while researchers tracked their itch intensity and quality of life. The goal was to see if this treatment could ease a distressing symptom that often has few good options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
Conditions
Explore the condition pages connected to this study.